DEVELOPMENT VELOCITY
Live / Registered — Registered (as of 02 Apr 2024)
What this means for you
Registered since 02 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97537410
- Registration number
- 7348341
- Mark type
- Stylized text
- Filed
- 05 Aug 2022
- Published for opposition
- 12 Sept 2023
- Registered
- 02 Apr 2024
- Attorney of record
- Neil M. Barnes
Goods and services
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software using artificial intelligence for use in pharmaceutical drug development, metadata tagging in the fields of healthcare and pharmaceuticals, identifying biomarkers, identifying mutations, identifying comorbidities, identifying side effects of drugs, identifying efficacy of drugs, identifying clinical study designs, identifying pharmacokinetics (PK), identifying study arms for clinical studies, identifying patient characteristics, identifying disease characteristics, identifying labs, identifying resistance markers, identifying disease therapies, vaccine development, diagnostics development in the fields of healthcare and pharmaceuticals, analyzing clinical data in the fields of healthcare and pharmaceuticals, analyzing clinical data in healthcare databases, health economics and outcomes research (HEOR) in the fields of healthcare and pharmaceuticals, conducting clinical trials in the fields of healthcare and pharmaceuticals, accessing and analyzing competitive intelligence information in the fields of healthcare and pharmaceuticals, accessing and analyzing market research in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a drug and over the life of a drug, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals, personalizing treatment options in the fields of healthcare and pharmaceuticals, and customer identification in the fields of healthcare and pharmaceuticals; Software as a service (SAAS) services featuring software for measurement of efficiency and success metrics for pharmaceutical products from lab to market; Platform as a service (PAAS) services featuring software platforms using artificial intelligence for use in pharmaceutical drug development, metadata tagging in the fields of healthcare and pharmaceuticals, identifying biomarkers, identifying mutations, identifying comorbidities, identifying side effects of drugs, identifying efficacy of drugs, identifying clinical study designs, identifying pharmacokinetics (PK), identifying study arms for clinical studies, identifying patient characteristics, identifying disease characteristics, identifying labs, identifying resistance markers, identifying disease therapies, vaccine development, diagnostics development in the fields of healthcare and pharmaceuticals, analyzing clinical data in the fields of healthcare and pharmaceuticals, analyzing clinical data in healthcare databases, health economics and outcomes research (HEOR) in the fields of healthcare and pharmaceuticals, conducting clinical trials in the fields of healthcare and pharmaceuticals, accessing and analyzing competitive intelligence information in the fields of healthcare and pharmaceuticals, accessing and analyzing market research in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a drug and over the life of a drug, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals, personalizing treatment options in the fields of healthcare and pharmaceuticals, and customer identification in the fields of healthcare and pharmaceuticals; Platform as a service (PAAS) services featuring software platforms for measurement of efficiency and success metrics for pharmaceutical products from lab to market
Owner
- SciMar ONE, Inc., Allentown, NJ, US
- SciMar ONE, Inc., Allentown, NJ, US
- SciMar ONE, Inc., Allentown, NJ, US
Prosecution history
- 02 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 28 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Feb 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Feb 2024 — USE AMENDMENT FILED
- 24 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Feb 2024 — TEAS STATEMENT OF USE RECEIVED
- 07 Nov 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Sept 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Sept 2023 — PUBLISHED FOR OPPOSITION
- 23 Aug 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Aug 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Aug 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Aug 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE